Consensus Cencora, Inc.

Stocks

COR

US03073E1055

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 16:00:03 2026-09-01 EDT			5-day change	1st Jan Change
330.97 ^USD	+2.28%		+0.89%	-2.01%

08-28	Walmart settles US government's opioid lawsuit, which sought billions, for $50 million	RE
08-19	RBC Initiates Cencora at Sector Perform With $330 Price Target	MT

Evolution of the Average Target: Cencora, Inc.

Evolution of the Target Price: Cencora, Inc.

Changes in Analyst Recommendations: Cencora, Inc.

38997eccb928c477.r7aewtLJ_pOjUqj9zyPz1kN-cDgTo7RSzQDGON0PhrE.yd7I97Swx8CRJ-yKoHesoS8nElNX_I0AjEOhf5VA5fad5tOt_4qK8OUR3w~518143a7cf49063c37c259f0888b9003

Analysts' recommendations: Cencora, Inc.

08-19	RBC Initiates Cencora at Sector Perform With $330 Price Target	MT
08-11	Wells Fargo Adjusts Price Target on Cencora to $395 From $331, Keeps Overweight Rating	MT
08-07	JPMorgan Adjusts Price Target on Cencora to $390 From $382	MT
08-06	Citigroup Adjusts Price Target on Cencora to $370 From $355	MT
08-06	Leerink Partners Adjusts Price Target on Cencora to $380 From $368	MT
08-06	Evercore ISI Adjusts Price Target on Cencora to $350 From $330	MT
08-06	Baird Adjusts Price Target on Cencora to $370 From $340	MT
08-06	UBS Adjusts Price Target on Cencora to $430 From $412, Maintains Buy Rating	MT
07-22	Baird Adjusts Price Target on Cencora to $340 From $337, Maintains Outperform Rating	MT
07-21	BofA Securities Adjusts Cencora Price Target to $310 From $285	MT
07-07	Evercore ISI Adjusts Price Target on Cencora to $330 From $300	MT
06-24	Argus Adjusts Price Target on Cencora to $340 From $4000, Maintains Buy Rating	MT
06-24	BofA Adjusts Price Target on Cencora to $285 From $280	MT
06-10	Barclays Cuts Cencora Price Target to $350 From $425, Maintains Overweight Rating	MT
05-21	Baird Adjusts Price Target on Cencora to $337 From $339, Maintains Outperform Rating	MT
05-11	Wells Fargo Adjusts Price Target on Cencora to $331 From $429	MT
05-08	McKesson's Fiscal 2027 Guidance 'Encouraging,' Cencora Selloff Overdone, Morgan Stanley Says	MT
05-08	Morgan Stanley Lowers Price Target on Cencora to $342 From $400, Keeps Overweight Rating	MT
05-07	UBS Adjusts Price Target on Cencora to $412 From $410, Maintains Buy Rating	MT
04-28	William Blair Initiates Cencora at Market Perform	MT
04-08	Evercore ISI Adjusts Price Target on Cencora to $360 From $420, Maintains Outperform Rating	MT
03-19	Baird Adjusts Price Target on Cencora to $420 From $415, Maintains Outperform Rating	MT
03-02	Leerink Partners Adjusts Price Target on Cencora to $447 From $410, Maintains Outperform Rating	MT
02-13	Barclays Adjusts Cencora Price Target to $425 From $400, Maintains Overweight Rating	MT
02-10	Wells Fargo Adjusts Price Target on Cencora to $429 From $405, Maintains Overweight Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CENCORA, INC.					+14.12%
	ABBOTT LABORATORIES					+8.92%
	MEDTRONIC PLC					+9.03%
	BECTON, DICKINSON AND COMPANY					+4.02%
	HOYA CORPORATION					+24.66%
	DEXCOM, INC.					+3.36%
	MEDLINE INC.					+27.36%
	WEST PHARMACEUTICAL SERVICES, INC.					+18.65%
	TERUMO CORPORATION					+24.53%
	STERIS PLC					+13.1%
	Average					+14.78%
	Weighted average by Cap.					+12.15%